VEGFR/PARP-IN-1 is a dual VEGFR/PARP inhibitor with anti-tumor and anti-metastatic activity; it inhibits DNA damage repair, induces apoptosis, arrests cells in the G2/M phase, and exhibits potent anti-proliferative effects against BRCA wild-type breast cancer cells (IC50 = 4.1 μM for MDA-MB-231 and 3.5 μM for MCF-7).